Current status of immunotherapy and gene therapy for high-grade gliomas.
about
Biomarkers for glioma immunotherapy: the next generationDendritic Cell-Based Immunotherapy Treatment for Glioblastoma MultiformeAdvances in diagnostic and treatment modalities for intracranial tumors.Induction of antigen-specific cytotoxic T-cell response by dendritic cells generated from ecto-mesenchymal stem cells infected with an adenovirus containing the MAGE-D4a gene.Stem cell in alternative treatments for brain tumors: potential for gene delivery.Brain Tumor Immunotherapy: What have We Learned so Far?Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.
P2860
Q26825496-83F6AB3A-6782-4232-A352-C9E2BC39788CQ28087485-6F53D643-BBA6-4092-94B9-F2160929B30BQ30358150-B0ECA5A0-BCEB-4A86-844C-A85A05A5B37BQ35988047-A5F50699-2995-4764-8464-F1D0882842D8Q38521752-670CFAD1-774B-4C08-AB30-7E6075E04767Q38542113-08078FF7-AEF8-4DBD-B8DE-F80267DEC1A3Q38912265-FFAD8CAF-27EE-4F0A-BE52-131B49B0A269
P2860
Current status of immunotherapy and gene therapy for high-grade gliomas.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current status of immunotherapy and gene therapy for high-grade gliomas.
@en
type
label
Current status of immunotherapy and gene therapy for high-grade gliomas.
@en
prefLabel
Current status of immunotherapy and gene therapy for high-grade gliomas.
@en
P2093
P2860
P1433
P1476
Current status of immunotherapy and gene therapy for high-grade gliomas.
@en
P2093
Aidnag Z Diaz
James C Marsh
Justin Goldfarb
Timothy D Shafman
P2860
P356
10.1177/107327481302000107
P577
2013-01-01T00:00:00Z